Stocks · Health care · Biological Products, (No Diagnostic Substances)

MiNK Therapeutics, Inc.

INKT Clue Score16
United States Fiscal year ends December CIK 0001840229 Results filed 13 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Buell
12 Oct 2026
Chief Executive Officer
Sell
6,938
$10.56
$73.27K
Barbara Ryan
4 Jun 2026
Director
Sell
1,000
$12.80
$12.80K
Barbara Ryan
4 Jun 2026
Director
Sell
500
$12.68
$6.34K
Barbara Ryan
10 Mar 2026
Director
Sell
500
$15.30
$7.65K
Barbara Ryan
10 Mar 2026
Director
Sell
500
$15.57
$7.78K
Barbara Ryan
10 Mar 2026
Director
Sell
300
$15.28
$4.58K
Barbara Ryan
9 Mar 2026
Director
Sell
200
$10.17
$2.03K
Barbara Ryan
2 Mar 2026
Director
Sell
100
$10.83
$1.08K
Barbara Ryan
27 Feb 2026
Director
Sell
400
$10.86
$4.34K

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 83,902
History held since 20 Oct 2021